Elekta donates USD 35,000 to prostate cancer research

ATLANTA, Dec. 4, 2014 /PRNewswire/ -- More than 150 Elekta employees from offices in a dozen countries participated in this year's Movember drive to raise awareness and funding in support of men's health – prostate and testicular cancer in particular. During the month called Movember (moustache [mo] + November), Elekta employees helped raise approximately USD 35,000.

Movember is an international, independent, annual fundraising event that encourages men (called "Mo Bros") to grow moustaches and women (called "Mo Sistas") to support them. Since 2003, Mo Bros and Mo Sistas globally have raised well over USD 500 million.

Niklas Savander, President and CEO says: "Elekta's commitment to improving the lives of people with cancer goes far beyond just selling hardware or software. I'm extremely proud of our colleagues who participated and especially those who donated to this cause. Their actions demonstrate that our dedication really is part of the Elekta culture."

Max Vere-Hodge, Movember Country Manager for Scandinavia, says: "Organizations such as Elekta have a huge impact in their support for Movember, both in terms of the funds they raise and also the awareness that they spread regarding men's health issues. Because it is a company that works directly with managing cancer, Elekta's employees are natural spokespeople for men's health. We are incredibly grateful and proud to have them as supporters in our fight to beat prostate and testicular cancer." 

This is the second year Elekta has officially participated in the fundraising campaign, which saw donations increase by 60 percent over last year.

Elekta's donation will go to the Movember Foundation's Global Action Plan (GAP), an international research collaboration initiative that provides researchers from around the world the opportunity to work together on specific projects. Funds raised are committed to combating prostate cancer, testicular cancer and mental health problems and have supported over 800 men's health programs to date.

For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: [email protected]
Time zone: CET: Central European Time

Kris Walmsley, Corporate Communications Manager, Elekta AB
Tel: +46 70 537 9545, e-mail: [email protected]
Time zone: CET: Central European Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/elekta-donates-usd-35000-to-prostate-cancer-research-300005094.html

SOURCE Elekta

Related Links

http://www.elekta.com